Participants in the life sciences sector operate in an increasingly challenging environment that requires a broad spectrum of sophisticated legal services. Our group counsels emerging and mature companies, investors, and investment banks in areas ranging from financing and venture capital to intellectual property, FDA regulatory and sales and marketing compliance, mergers and acquisitions, licensing, employment, litigation, antitrust, product liability, and other general commercial and clinical matters relevant to the life sciences industry. The team–including former in-house counsel from large and midsize pharmaceutical, medical device, and biotech companies–anticipates and efficiently addresses client needs.

We have been described as “beyond responsive”–we care deeply about our clients and see their day-to-day battles as our own. Our broad industry practice representing emerging companies, multinational publicly traded companies, venture funds, hedge funds, private equity firms, and life sciences-focused investment banks gives us insight into industry dynamics and helps us develop creative solutions to complex legal issues.




Practice Leaders


Michael J. Lerner
Group Chair
973.597.6394


John D. Hogoboom
Vice Chair
646.414.6846


Robert J. Paradiso
Vice Chair
973.597.2404


Herschel S. Weinstein
Vice Chair
646.414.6903


Related Information

Lawyers
News
Events
Publications